State Street
ERO.L
IE00BKWQ0Q14
State Street® SPDR® MSCI Europe UCITS ETF
Loading chart...

Risk & Diversification Scores

Transparent evaluation of price volatility (SRI) and 4-dimensional portfolio diversification.

Volatility Risk Score
5/7 Elevated
5 / 7 SRI PRIIPs Risk Class

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon).

Volatility (5Y)
13.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-15.8%
Deepest Drawdown
Sharpe Ratio
0.51
Good (0.5 - 1.0)
Rec. Holding Period
5 - 10+ Years
Investment Horizon
Elevated Risk / Growth: Score Basis:
Diversification Score
Broadly Diversified (< 35%)
68 / 100 Portfolio Diversification
4 Dimensions: Holdings (30%) • Sectors (25%) • Industries (25%) • Regions (20%)

High risk diversification: No dependency on individual heavyweights.

Top 10 Holdings
21.3%
Low Concentration
Effective Holdings
~162
of 387 holdings
Top Sector
25.8%
Financial Services
Top Region / Country
21.8%
United Kingdom
Excellent multi-dimensional diversification across holdings, industries, and geographies.

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +9.5%
3 Years 12.1% -12.8% 0.98 +14.4%
5 Years 13.8% -15.8% 0.51 +9.6%
10 Years 14.6% -28.4% 0.4 +8.4%

Notes & Warnings

🟢 Favorable / fair valuation: Avg P/E of 17.2
🟢 Balanced position distribution (< 35% in Top 10)
Solid fund volume
🟡 Moderate analyst coverage (16.1 analysts)
⚠️ Elevated Economic Cyclicality: 53% in cyclical industries – more vulnerable to economic downturns.
⚠️ Elevated Interest Rate Sensitivity: 37% in rate-sensitive or leverage-heavy industries (real estate, banks, utilities).
⚠️ Elevated Regulatory & Policy Risk: 61% in heavily regulated industries (defense, regulated utilities, healthcare policy).
🟢 Strong Long-Term Stability: The asset exhibits consistently low volatility across 5 and 10 years (<16% p.a.).
ende